查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594545

核苷酸市场：按产品类型、应用划分 - 2025-2030 年全球预测

Nucleotides Market by Product Type (Food Grade, Lab Grade), Application (Drug Discovery, Food & Animal Feed Additives, Pharmaceutical) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年核苷酸市值为6.0484亿美元，预计2024年将达到6.523亿美元，复合年增长率为8.33%，预计到2030年将达到10.5919亿美元。

核苷酸是有机分子，是 DNA 和 RNA 等核酸的组成部分，在细胞过程中发挥重要作用。他们的需求范围从遗传讯息的储存和传递到能量代谢的重要前体。核苷酸的应用多种多样，包括用于抗病毒治疗的药物、牲畜和人类的营养食品以及用于研究和诊断的分子生物学工具。市场最终用途包括医疗和製药、农业和生物技术领域。核苷酸市场受到蓬勃发展的生物技术产业以及对旨在增强肠道健康和免疫功能的动物强化产品不断增长的需求的显着影响。此外，对个人化医疗的日益关注和基因研究的进步正在进一步推动市场扩张。然而，该市场面临的主要挑战之一是核苷酸合成的高成本和治疗应用中潜在的监管障碍。

主要市场统计
基准年[2023] 60484万美元
预测年份 [2024] 6.523 亿美元
预测年份 [2030] 1,059,190,000 美元
复合年增长率（%） 8.33%

新的商机在于开髮用于治疗用途的新型核苷酸类似物，特别是用于标靶癌症治疗和病毒感染控制。此外，透过富含核苷酸的动物饲料扩大在水产养殖中的应用并提高农业产量也提供了有希望的成长途径。为了利用这些机会，公司应该投资于降低成本和提高纯度的创新生产技术，并与研究机构建立策略伙伴关係关係以推动产品开发。然而，市场成长受到合成核苷酸成本效益生产和大规模保持品质一致性方面的技术挑战的限制。此外，不断变化的监管和智慧财产权问题可能会进一步影响市场动态。最佳创新领域包括开发永续生产方法、提高核苷酸稳定性以延长保质期以及探索多功能核苷酸产品。该市场的特点是技术快速进步和竞争格局激烈，协作和持续创新是保持市场主导地位的关键。

市场动态：揭示快速发展的核苷酸市场的关键市场洞察

供需的动态相互作用正在改变核苷酸市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 对核苷酸补充品的需求不断增长
    • 增加核苷酸在诊断研究中的使用
    • 动物饲料中的使用量迅速增加
  • 市场限制因素
    • 核苷酸产品高成本
  • 市场机会
    • 提高核苷酸产量
    • 市场参与企业之间的合併活动增加，以实现更好的商业化
  • 市场问题
    • 关于核苷酸的严格规则

波特五力：驾驭核苷酸市场的策略工具

波特的五力框架是了解核苷酸市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解核苷酸市场的外部影响

外部宏观环境因素在塑造核苷酸市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解核苷酸市场的竞争格局

核苷酸市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵：核苷酸市场供应商绩效评估

FPNV定位矩阵是评估核苷酸市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製核苷酸市场的成功之路

核苷酸市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对核苷酸补充品的需求增加
      • 诊断研究中核苷酸的使用增加
      • 在动物饲料中的指数级使用
    • 抑制因素
      • 核苷酸产品高成本
    • 机会
      • 提高核苷酸产量
      • 市场相关人员之间的合併活动增加，以实现更好的商业化
    • 任务
      • 关于核苷酸的严格规则
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 核苷酸市场：依产品类型

  • 介绍
  • 食品级
  • 实验室级

第七章 核苷酸市场：依应用分类

  • 介绍
  • 药物发现
  • 食品和动物饲料添加剂
  • 製药

第八章美洲核苷酸市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太核苷酸市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲的核苷酸市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Biosynth Ltd.
  • Bosche Scientific LLC
  • CJ CheilJedang Corp.
  • Daesang Corporation
  • Ebrator Biochemicals
  • Glentham Life Sciences Ltd.
  • Jena Bioscience GmbH
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • New England Biolabs Inc.
  • Otto Chemie Pvt. Ltd.
  • Promega Corporation
  • Prosol SpA
  • Thermo Fisher Scientific Inc.
Product Code: MRR-957C47F9323F

The Nucleotides Market was valued at USD 604.84 million in 2023, expected to reach USD 652.30 million in 2024, and is projected to grow at a CAGR of 8.33%, to USD 1,059.19 million by 2030.

Nucleotides are organic molecules that serve as the building blocks of nucleic acids like DNA and RNA, playing critical roles in cellular processes. Their necessity spans from genetic information storage and transfer to being essential precursors in energy metabolism. The application of nucleotides is diverse, encompassing pharmaceuticals for antiviral therapies, dietary supplements for livestock and humans, and molecular biology tools for research and diagnostics. The market's end-use scope includes healthcare and pharmaceuticals, agriculture, and biotechnology sectors. The nucleotide market is significantly influenced by the burgeoning biotechnology industry and the increasing demand for fortified animal nutrition products, which aim to enhance gut health and immune function. Additionally, the rising focus on personalized medicine and advancements in genetic research further fuel market expansion. However, one of the primary challenges faced by this market is the high cost of nucleotide synthesis and potential regulatory hurdles in therapeutic applications.

KEY MARKET STATISTICS
Base Year [2023] USD 604.84 million
Estimated Year [2024] USD 652.30 million
Forecast Year [2030] USD 1,059.19 million
CAGR (%) 8.33%

Emerging opportunities lie in the development of novel nucleotide analogs for therapeutic use, particularly in targeted cancer treatments and viral infection management. Additionally, expanding applications in aquaculture and improved agricultural yields through nucleotide-enhanced animal feed represent prospective growth avenues. To capitalize on these opportunities, companies should invest in innovative production technologies that reduce costs and improve purity, as well as form strategic partnerships with research institutions to drive product development. Yet, market growth is constrained by technological challenges in the cost-efficient production of synthetic nucleotides and maintaining quality consistency at scale. Moreover, evolving regulations and intellectual property rights issues could further impact market dynamics. The best areas of innovation include developing sustainable production methods, enhancing nucleotide stability for extended shelf life, and exploring multi-functional nucleotide products. The market is characterized by rapid technological advancements and a competitive landscape, with collaboration and continual innovation being key to maintaining an edge in the market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nucleotides Market

The Nucleotides Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand of nucleotide supplements
    • Increase use of nucleotide in diagnostic research
    • Exponential use in animal feed
  • Market Restraints
    • High cost of nucleotide based products
  • Market Opportunities
    • Improvements in nucleotide manufacturing
    • Increasing amalgamation activities between market players for better commercialization
  • Market Challenges
    • Stringent rules regarding nucleotides

Porter's Five Forces: A Strategic Tool for Navigating the Nucleotides Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nucleotides Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nucleotides Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nucleotides Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nucleotides Market

A detailed market share analysis in the Nucleotides Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nucleotides Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nucleotides Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nucleotides Market

A strategic analysis of the Nucleotides Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nucleotides Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Biosynth Ltd., Bosche Scientific LLC, CJ CheilJedang Corp., Daesang Corporation, Ebrator Biochemicals, Glentham Life Sciences Ltd., Jena Bioscience GmbH, Merck KGaA, Meridian Bioscience, Inc., New England Biolabs Inc., Otto Chemie Pvt. Ltd., Promega Corporation, Prosol S.p.A., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Nucleotides Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Food Grade and Lab Grade.
  • Based on Application, market is studied across Drug Discovery, Food & Animal Feed Additives, and Pharmaceutical.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand of nucleotide supplements
      • 5.1.1.2. Increase use of nucleotide in diagnostic research
      • 5.1.1.3. Exponential use in animal feed
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of nucleotide based products
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements in nucleotide manufacturing
      • 5.1.3.2. Increasing amalgamation activities between market players for better commercialization
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent rules regarding nucleotides
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Nucleotides Market, by Product Type

  • 6.1. Introduction
  • 6.2. Food Grade
  • 6.3. Lab Grade

7. Nucleotides Market, by Application

  • 7.1. Introduction
  • 7.2. Drug Discovery
  • 7.3. Food & Animal Feed Additives
  • 7.4. Pharmaceutical

8. Americas Nucleotides Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Nucleotides Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Nucleotides Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Biosynth Ltd.
  • 3. Bosche Scientific LLC
  • 4. CJ CheilJedang Corp.
  • 5. Daesang Corporation
  • 6. Ebrator Biochemicals
  • 7. Glentham Life Sciences Ltd.
  • 8. Jena Bioscience GmbH
  • 9. Merck KGaA
  • 10. Meridian Bioscience, Inc.
  • 11. New England Biolabs Inc.
  • 12. Otto Chemie Pvt. Ltd.
  • 13. Promega Corporation
  • 14. Prosol S.p.A.
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. NUCLEOTIDES MARKET RESEARCH PROCESS
  • FIGURE 2. NUCLEOTIDES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NUCLEOTIDES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEOTIDES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES NUCLEOTIDES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES NUCLEOTIDES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. NUCLEOTIDES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. NUCLEOTIDES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NUCLEOTIDES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NUCLEOTIDES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEOTIDES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NUCLEOTIDES MARKET DYNAMICS
  • TABLE 7. GLOBAL NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEOTIDES MARKET SIZE, BY FOOD GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEOTIDES MARKET SIZE, BY LAB GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEOTIDES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEOTIDES MARKET SIZE, BY FOOD & ANIMAL FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES NUCLEOTIDES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. NUCLEOTIDES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. NUCLEOTIDES MARKET, FPNV POSITIONING MATRIX, 2023